<SEC-DOCUMENT>9999999997-20-000793-index.html : 20200318 <SEC-HEADER>9999999997-20-000793.hdr.sgml : 20200318 <ACCEPTANCE-DATETIME>20200219142309 ACCESSION NUMBER: 9999999997-20-000793 CONFORMED SUBMISSION TYPE: SEC STAFF LETTER CATEGORY: REDACTED EXHIBIT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200219 ACTION DATE: 20200219 RECEIVED DATE: 20200219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SEC STAFF LETTER BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>REDACTED EXHIBIT <SEQUENCE>1 <FILENAME>filename1.pdf <TEXT> Document 1 - file: filename1.pdf
</DOCUMENT> </SEC-DOCUMENT>